<DOC>
	<DOCNO>NCT01970501</DOCNO>
	<brief_summary>This study do compare effect bucindolol hydrochloride ( bucindolol ) metoprolol succinate ( Toprol-XL ) recurrence symptomatic atrial fibrillation/atrial flutter patient heart failure specific genotype beta-1 adrenergic receptor .</brief_summary>
	<brief_title>Genetically Targeted Therapy Prevention Symptomatic Atrial Fibrillation Patients With Heart Failure</brief_title>
	<detailed_description>The goal GENETIC-AF trial demonstrate superiority pharmacogenetically target bucindolol compare metoprolol prevention symptomatic atrial fibrillation atrial flutter genotype-defined population heart failure and/or reduce leave ventricular ejection fraction high risk atrial fibrillation/atrial flutter recurrence .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Atrial Flutter</mesh_term>
	<mesh_term>Metoprolol</mesh_term>
	<mesh_term>Bucindolol</mesh_term>
	<criteria>Key Must weigh least 40 kg Possess Î²1389 Arg/Arg genotype Left Ventricular Ejection Fraction ( LVEF ) &lt; 0.50 assess within 12 month prior Screening At least one episode symptomatic paroxysmal persistent AF within 180 day Screening Clinically appropriate electrical cardioversion ( ECV ) AF/AFL present study drug initiation Receiving appropriate anticoagulation therapy prior Randomization Key NYHA Class IV symptoms time Randomization Significant fluid overload Randomization Permanent AF Screening More two previous ECV within 6 month Randomization recent ECV fail produce SR Presence LVAD , likely requirement LVAD placement within 6 month Randomization History successful atrioventricular ( AV ) node ablation History AF/AFL ablation within 30 day Randomization Evidence appropriate firing implant cardioverterdefibrillator ( ICD ) device ventricular tachycardia ( VT ) ventricular fibrillation ( VF ) within 90 day Randomization</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>atrial fibrillation</keyword>
	<keyword>atrial flutter</keyword>
	<keyword>heart failure</keyword>
	<keyword>reduce left ventricle ejection fraction</keyword>
	<keyword>electrical cardioversion</keyword>
	<keyword>GENETIC-AF</keyword>
	<keyword>Medtronic</keyword>
	<keyword>bucindolol</keyword>
	<keyword>pharmacogenetic</keyword>
	<keyword>ARCA</keyword>
	<keyword>Toprol</keyword>
	<keyword>Toprol-XL</keyword>
	<keyword>Metoprolol</keyword>
	<keyword>Metoprolol succinate</keyword>
</DOC>